MENU

QNCX Quince Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology
QNCX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
QNCX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

QNCX is expected to report earnings to fall 23.08% to -10 cents per share on March 04

Quince Therapeutics QNCX Stock Earnings Reports
Q4'24
Est.
$-0.10
Q3'24
Missed
by $0.03
Q1'23
Missed
by $0.03
Q4'22
Beat
by $0.14
Q3'22
Beat
by $0.06
The last earnings report on November 13 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 671.12K shares outstanding, the current market capitalization sits at 82.23M.
A.I. Advisor
published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

QNCX and Stocks

Correlation & Price change

A.I.dvisor tells us that QNCX and MNPR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+19.50%
MNPR - QNCX
28%
Poorly correlated
-5.20%
KOD - QNCX
28%
Poorly correlated
-3.64%
LQDA - QNCX
24%
Poorly correlated
-2.39%
MDXG - QNCX
23%
Poorly correlated
+23.56%
FENC - QNCX
22%
Poorly correlated
-1.79%
More